Acetylation regulates the stability of glutamate carboxypeptidase II protein in human astrocytes

Biochemical and Biophysical Research Communications

Volumn 450, Issue 1, 2014, Pages 372-377

  Choi, Ji Young ^a   Kim, Jong Ho ^a   Jo, Sangmee Ahn ^a  

^a Dankook University   (South Korea)

Author keywords

Acetylation; Glutamate carboxypeptidase II; Histone acetyltransferase; Histone deacetylase; Protein stability; Valproic acid

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLOHEXIMIDE; GLUTAMATE CARBOXYPEPTIDASE II; VALPROIC ACID;

ACETYLATION; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME STABILITY; EPIGENETICS; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ACETYLATION; GLUTAMATE CARBOXYPEPTIDASE II; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; PROTEIN STABILITY; VALPROIC ACID;

ACETYLATION; ANTIGENS, SURFACE; ASTROCYTES; CELL LINE; ENZYME STABILITY; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; VALPROIC ACID;

EID: 84904730242     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.05.132     Document Type: Article

References (27)

1. M. Rovenska, K. Hlouchova, P. Sacha, P. Mlcochova, V. Horak, J. Zamecnik, C. Barinka, and J. Konvalinka Tissue expression and enzymologic characterization of human prostate specific membrane antigen and its rat and pig orthologs Prostate 68 2008 171 182
2. C.H. Halsted, E.H. Ling, R. Luthi-Carter, J.A. Villanueva, J.M. Gardner, and J.T. Coyle Folypoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II J. Biol. Chem. 7 1998 20417 20424
3. J.S. Ross, C.E. Sheehan, H.A. Fisher, R.P. Kaufman Jr, P. Kaur, K. Gray, I. Webb, G.S. Gray, R. Mosher, and B.V. Kallakury Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer Clin. Cancer Res. 15 2003 6357 6362
4. P. Sácha, J. Zámecník, C. Barinka, K. Hlouchová, A. Vícha, P. Mlcochová, I. Hilgert, T. Eckschlager, and J. Konvalinka Expression of glutamate carboxypeptidase II in human brain Neuroscience 144 2007 1361 1372
5. 3H]norepinephrine release from rat hippocampal slices J. Pharmacol. Exp. Ther. 266 1993 796 803
6. B. Wroblewska, J.T. Wroblewski, S. Pshenichkin, A. Surin, S.E. Sullivan, and J.H. Neale N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells J. Neurochem. 69 1997 174 181
7. G. Tsai, L.A. Passani, B.S. Slusher, R. Carter, L. Baer, J.E. Kleinman, and J.T. Coyle Abnormal excitatory neurotransmitter metabolism in schizophrenic brains Arch. Gen. Psychiatry 52 1995 829 836
8. T.R. Guilarte, D.A. Hammoud, J.L. McGlothan, B.S. Caffo, C.A. Foss, A.P. Kozikowski, and M.G. Pomper Dysregulation of glutamate carboxypeptidase II in psychiatric disease Schizophr. Res. 99 2008 324 332
9. S.R. Chen, K.M. Wozniak, B.S. Slusher, and H.L. Pan Effect of 2-(phosphono-methyl)-pentanedioic acid on allodynia and different ectopic discharges in a rat model of neuropathic pain J. Pharmacol. Exp. Ther. 300 2002 662 667
10. B.S. Slusher, J.J. Vornov, A.G. Thomas, P.D. Hurn, I. Harukuni, A. Bhardwaj, R.J. Traystman, M.B. Robinson, P. Britton, X.C. Lu, F.C. Tortella, K.M. Wozniak, M. Yudkoff, B.M. Potter, and P.F. Jackson Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury Nat. Med. 5 1999 1396 1402
11. W. Zhang, B. Slusher, Y. Murakawa, K.M. Wozniak, T. Tsukamoto, P.F. Jackson, and A.A. Sima GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats J. Neurol. Sci. 194 2002 21 28
12. G.D. Ghadge, B.S. Slusher, A. Bodner, M.D. Canto, K. Wozniak, A.G. Thomas, C. Rojas, T. Tsukamoto, P. Majer, R.J. Miller, A.L. Monti, and R.P. Roos Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models Proc. Natl. Acad. Sci. U.S.A. 100 2003 9554 9559
13. M.J. Kim, S.S. Chae, Y.H. Koh, S.K. Lee, and S.A. Jo Glutamate carboxypeptidase II: an amyloid peptide-degrading enzyme with physiological function in the brain FASEB J. 24 2010 4491 4502
14. W. Loscher Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy CNS Drugs 16 2002 669 694
15. T.R. Henry The history of valproate in clinical neuroscience Psychopharmacol. Bull. 37 2003 5 16
16. T.W. Bredy, H. Wu, C. Crego, J. Zellhoefer, Y.E. Sun, and M. Barad Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear Learn. Mem. 14 2007 268 276
17. E. Dong, M. Nelson, D.R. Grayson, E. Costa, and A. Guidotti Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation Proc. Natl. Acad. Sci. U.S.A. 105 2008 13614 13619
18. D.P. Gavin, S. Kartan, K. Chase, S. Jayaraman, and R.P. Sharma Histone deacetylase inhibitors and candidate gene expression: an in vivo and in vitro approach to studying chromatin remodeling in a clinical population J. Psychiatr. Res. 43 2009 870 876
19. F. Wang, C.H. Chan, K. Chen, X. Guan, H.K. Lin, and Q. Tong Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation Oncogene 31 2012 1546 1557
20. N.A. Barlev, L. Liu, N.H. Chehab, K. Mansfield, K.G. Harris, T.D. Halazonetis, and S.L. Berger Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases Mol. Cell 8 2001 1243 1254
21. J.S. Waby, H. Chriakkal, C. Yu, G.J. Griffiths, R. Benson, C.D. Bingle, and B.M. Corfe Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line Mol. Cancer 9 2010 10.1186/1476-4598-9-275
22. C. Choudhary, C. Kumar, F. Gnad, M.L. Neilsen, M. Rehman, T.C. Walther, J.V. Olsen, and M. Mann Lysine acetylation targets protein complexes and co-regulates major cellular functions Science 325 2009 834 840
23. G.W. Kim, and X.J. Yang Comprehensive lysine acetylomes emerging from bacteria to humans Trends Biochem. Sci. 36 2011 211 220
24. S.H. Kim, J.W. Jeong, J.A. Park, J.W. Lee, J.H. Seo, B.K. Jung, M.K. Bae, and K.W. Kim Regulation of the HIF-1 stability by histone deacetylases Oncol. Rep. 17 2007 647 651
25. H. Geng, Q. Liu, C. Xue, L.L. David, T.M. Beer, G.V. Thomas, M.S. Dai, and D.Z. Qian HIF1 protein stability is increased by acetylation at lysine 709 J. Biol. Chem. 12 2012 35496 35505
26. S.J. Lee, K. Lee, X. Yang, C. Jung, T. Gardner, H.S. Kim, M.H. Jeng, and C. Kao NFATc1 with AP-3 site binding specificity mediates gene expression of prostate-specific-membrane-antigen J. Mol. Biol. 330 2003 749 760
27. L. Han, D.L. Wong, G. Tsai, Z. Jiang, and J.T. Coyle Promoter analysis of human glutamate carboxypeptidase II Brain Res. 1170 2007 1 12